Search Results - poulami+majumder

2 Results Sort By:
Peptide Hydrogels for Delivery of Immunosuppressive Drugs and Uses Thereof
Summary: The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a hydrogel-based delivery system for the local administration of tofacitinib to improve transplant outcomes. Description of Technology: Unmet Need More than 1 million tissue transplantations are performed each year. Organ transplantation therapies...
Published: 11/6/2024   |   Inventor(s): Giorgio Raimondi, Joel Schneider, Poulami Majumder
Keywords(s):  
Category(s): Application > Therapeutics, Collaboration Sought > Collaboration, TherapeuticArea > Immunology, TherapeuticArea > Cardiology, TherapeuticArea > Nephrology
Nanoparticle-hydrogel Composite for Nucleic Acid Molecule Delivery
Abstract: Mesothelioma is an aggressive cancer covering anatomic surfaces (e.g. lining of the lungs, heart, abdomen, etc.) that resists multi-modality therapies. Regional recurrence of mesothelioma from residual tumor cells prevents long-term benefits after surgical resection. Furthermore, there is no clinical consensus on intracavitary adjuvants that...
Published: 4/8/2024   |   Inventor(s): Joel Schneider, Poulami Majumder, Chuong Hoang, Anand Singh
Keywords(s): Hoang, Hydrogel, Mesothelioma, MicroRNA, Nanoparticle, Schneider, Surface Cancer
Category(s): TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, Application > Therapeutics